Equities

EBR Systems Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

EBR Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.775
  • Today's Change-0.015 / -1.90%
  • Shares traded325.46k
  • 1 Year change-53.31%
  • Beta1.0602
Data delayed at least 20 minutes, as of Feb 17 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

EBR Systems, Inc. is a medical device company. The Company is developing the wireless stimulation endocardially cardiac resynchronization therapy (WiSE CRT) System an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of wires or leads. This investigational device delivers left-ventricle endocardial pacing for CRT without wires or leads. The WiSE CRT System developed a new approach to cardiac pacing, with the potential to transform CRT delivery and benefit patients who have not succeeded with conventional CRT. It operates wholly owned subsidiaries in Australia, EBR Systems (AUST) Pty Ltd, and the United Kingdom, EBR Systems (UK) Limited, which conduct clinical trials and work on intellectual property development in their respective regions.

  • Revenue in AUD (TTM)963.94k
  • Net income in AUD-63.35m
  • Incorporated2003
  • Employees--
  • Location
    EBR Systems Inc480 Oakmead ParkwaySUNNYVALE 94085United StatesUSA
  • Phone+1 (408) 720-1906
  • Fax+1 (408) 720-1996
  • Websitehttps://ebrsystemsinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lumos Diagnostics Holdings Ltd17.53m-10.16m214.17m----23.22--12.22-0.0148-0.01480.02580.01160.52057.044.91---30.15-40.19-54.60-61.1662.9552.57-57.93-132.460.6816-10.690.5315--11.4017.1216.40---61.58--
Aroa Biosurgery Ltd77.16m-1.55m236.65m261.00--3.00140.673.07-0.0045-0.00450.22360.22850.84321.563.08---1.70-8.53-1.85-9.7585.0782.71-2.01-15.205.740.31420.0706--22.6327.5664.12--14.62--
Orthocell Ltd8.85m-8.57m249.60m----15.37--28.20-0.0375-0.03750.03970.05990.28622.319.20---27.70-28.14-34.17-33.4768.9871.87-96.78-167.824.78--0.0381--36.4161.65-19.30--45.43--
Saluda Medical Inc-100.00bn-100.00bn257.06m--------------------------------------------------36.13---52.62------
Paragon Care Ltd3.62bn20.57m331.06m0.0016.101.006.570.09150.01240.01242.180.19933.0211.9010.33--1.721.794.474.079.048.900.56880.60810.61551.770.4699--21.7273.23151.52--18.34--
EchoIQ Ltd101.41k-13.26m349.78m----15.17--3,449.13-0.0226-0.02260.00020.03530.0064--0.6446---83.87-68.78-89.84-81.95-----13,078.12-3,892.98----0.00--127.89-31.65-145.19---16.56--
EBR Systems Inc963.94k-63.35m355.53m----6.50--368.83-0.1692-0.16920.00250.12150.0074--0.4935---48.75-60.71-53.75-74.7645.20---6,572.14--7.01-15.000.5131-------16.44--2.46--
Data as of Feb 17 2026. Currency figures normalised to EBR Systems Inc's reporting currency: Australian Dollar AUD

Institutional shareholders

1.87%Per cent of shares held by top holders
HolderShares% Held
Pengana Capital Ltd.as of 31 Oct 20255.59m1.24%
FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 20252.81m0.63%
Data from 30 Sep 2025 - 31 Oct 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.